Volume | 820,551 |
|
|||||
News | - | ||||||
Day High | 23.22 | Low High |
|||||
Day Low | 22.28 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Corcept Therapeutics Inc | CORT | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
22.28 | 22.28 | 23.22 | 22.80 | 22.21 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
10,620 | 820,551 | US$ 22.87 | US$ 18,764,847 | - | 20.84 - 34.275 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:33:53 | formt | 115 | US$ 21.90 | USD |
Corcept Therapeutics (CORT) Options Flow Summary
Corcept Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.36B | 103.52M | - | 482.38M | 106.14M | 1.03 | 22.25 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Corcept Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CORT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 22.60 | 24.23 | 20.84 | 22.52 | 1,794,374 | -0.70 | -3.10% |
1 Month | 24.95 | 26.10 | 20.84 | 23.49 | 1,047,488 | -3.05 | -12.22% |
3 Months | 21.40 | 26.10 | 20.84 | 23.47 | 1,072,110 | 0.50 | 2.34% |
6 Months | 27.69 | 33.28 | 20.84 | 24.52 | 1,213,260 | -5.79 | -20.91% |
1 Year | 22.16 | 34.275 | 20.84 | 25.41 | 937,156 | -0.26 | -1.17% |
3 Years | 24.15 | 34.275 | 15.825 | 23.15 | 872,578 | -2.25 | -9.32% |
5 Years | 12.05 | 34.275 | 9.55 | 20.19 | 960,385 | 9.85 | 81.74% |
Corcept Therapeutics Description
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. |